| Trial ID: | L6698 |
| Source ID: | NCT01530178
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Sitagliptin Dose Determination Study
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01530178/results
|
| Conditions: |
Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Placebo Oral Tablet
|
| Outcome Measures: |
Primary: Better Targeted Blood Glucose Levels, The current trial is designed to detect a significant difference in the mean glucose levels in the treatment group, 1 Year |
|
| Sponsor/Collaborators: |
Sponsor: Albert Einstein College of Medicine
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
8
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2011-11
|
| Completion Date: |
2015-03
|
| Results First Posted: |
2018-07-16
|
| Last Update Posted: |
2018-07-16
|
| Locations: |
Albert Einstein College of Medicine CRC, Bronx, New York, 10461, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01530178
|
